You searched for T cells - Page 27 of 41

blood cancer stem cell therapy brain cancer

News and Trends 11 Sep 2019

Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer

…cells. In the lab, Genenta makes the stem cells mature into immune cells called tumor-infiltrating monocytes, and the company implants them into the patient’s tumor where they can recruit the…

September 11, 2019 - 3 minutesmins - By Jonathan Smith

Weekly Roundup 15 Dec 2023

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

…cells to treat cancer. The two companies will assess the combination therapies’ performances in preclinical studies next year. The FLEX-NK antibodies are based on a tetravalent, multifunctional format with flexible…

December 15, 2023 - 14 minutesmins - By Roohi Mariam Peter

Best in Biotech 20 Feb 2018

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

…of CAR-T cell therapy and T-cell receptor technologies. Both approaches have shown great promise for cancer treatment, with the two first CAR-T therapies launched into the market in 2017. To…

February 20, 2018 - 11 minutesmins - By Karen O’Hanlon Cohrt

News and Trends 2 May 2017

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents

…Celyad’s allogeneic CAR-T therapy. By using T cells derived from a healthy donor, allogeneic CAR-T therapy is thought to be more cost- and time-effective, allowing for off-the-shelf available T cells…

May 2, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 9 Jan 2018

Scancell and BioNTech Will Combine Their Expertise to Fight Cancer

…for the treatment of cancer and it has announced that it will come together with Europe’s largest private biopharma, BioNTech, to develop T-cell receptor (TCR)-based therapies. In particular, the collaboration…

January 9, 2018 - 3 minutesmins - By Alex Dale

News and Trends 29 Sep 2016

Debunking the Immuno-Oncology Hype: is it as good as it sounds?

…are now advancing their programs in CAR-T, the breakthrough therapy that everyone’s after. In this treatment, the patient’s T-cells are engineered in vitro, rewired to attack a specific tumor antigen…

September 29, 2016 - 5 minutesmins - By Clara Rodríguez Fernández

In Depth 15 Feb 2024

Turning the tide: recent advancements in childhood cancer research

…Last year, BrainChild took its CAR-T candidate to the clinic to evaluate four different targets. It plans to create a CAR-T cell therapy platform that can address multiple targets, include…

February 15, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 13 May 2022

Domain Therapeutics Bags €39M to Block GPCRs in Cancer Immunotherapy

…are proteins on the surface of immune T cells that normally prevent an immune response from being so strong it destroys healthy cells in the body. Cancer cells can exploit…

May 13, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 13 Apr 2023

Aspect and Novo Nordisk working on bioprinted tissue for diabetes and obesity

…manufacturing. Under the terms of the agreement, Novo Nordisk will receive an exclusive, worldwide license to use Aspect’s bioprinting technology to develop up to four products for the treatment of…

April 13, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 14 Mar 2023

How the microbiome can predict cancer immunotherapy success

…modified T cells are then able to seek out and destroy the tumor cells in the body. However, there are still big differences between patients when it comes to treatment…

March 14, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 16 Feb 2018

French Biotech Gets a CRISPR Patent for CAR-T Research

Update (16/02/2018): On top of the European patent it got last July, Cellectis now also has two US patents to use CRISPR technology to make CAR-T cells. Cellectis has said…

February 16, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 19 Sep 2016

Abingworth launches UK Immuno-Oncology Startup with Seed Funding

…than their blood-resident alpha-beta counterparts at invading and killing solid tumors. Gamma-delta T cells exhibit consistent levels of expression of interferon gamma, which Mehta believes is the key to this…

September 19, 2016 - 3 minutesmins - By Evelyn Warner

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: T cells

Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents

Scancell and BioNTech Will Combine Their Expertise to Fight Cancer

Debunking the Immuno-Oncology Hype: is it as good as it sounds?

Turning the tide: recent advancements in childhood cancer research

Domain Therapeutics Bags €39M to Block GPCRs in Cancer Immunotherapy

Aspect and Novo Nordisk working on bioprinted tissue for diabetes and obesity

How the microbiome can predict cancer immunotherapy success

French Biotech Gets a CRISPR Patent for CAR-T Research

Abingworth launches UK Immuno-Oncology Startup with Seed Funding

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!